297 related articles for article (PubMed ID: 22733089)
1. Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?
Kansara S; Trivedi A; Chen S; Jankovic J; Le W
J Neural Transm (Vienna); 2013 Jan; 120(1):197-210. PubMed ID: 22733089
[TBL] [Abstract][Full Text] [Related]
2. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
Le W; Dong J; Li S; Korczyn AD
Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
[TBL] [Abstract][Full Text] [Related]
3. Disease modification in Parkinson's disease.
Henchcliffe C; Severt WL
Drugs Aging; 2011 Aug; 28(8):605-15. PubMed ID: 21812497
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis.
Bhat S; Acharya UR; Hagiwara Y; Dadmehr N; Adeli H
Comput Biol Med; 2018 Nov; 102():234-241. PubMed ID: 30253869
[TBL] [Abstract][Full Text] [Related]
5. [Does early detection of non-motor symptoms facilitate early treatment of Parkinson's disease?].
Hasegawa K
Brain Nerve; 2012 Apr; 64(4):453-61. PubMed ID: 22481518
[TBL] [Abstract][Full Text] [Related]
6. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease: from genetics to treatments.
Fan HC; Chen SJ; Harn HJ; Lin SZ
Cell Transplant; 2013; 22(4):639-52. PubMed ID: 23127617
[TBL] [Abstract][Full Text] [Related]
8. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.
Ahlskog JE
Parkinsonism Relat Disord; 2009 Dec; 15(10):721-7. PubMed ID: 19815446
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the diagnosis and management of Parkinson's disease.
Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.
von Linstow CU; Gan-Or Z; Brundin P
Transl Neurodegener; 2020 Oct; 9(1):39. PubMed ID: 33066808
[TBL] [Abstract][Full Text] [Related]
12. Profiling Non-motor Symptoms in Monogenic Parkinson's Disease.
Liu X; Le W
Front Aging Neurosci; 2020; 12():591183. PubMed ID: 33192488
[TBL] [Abstract][Full Text] [Related]
13. Premotor Parkinson's disease: concepts and definitions.
Siderowf A; Lang AE
Mov Disord; 2012 Apr; 27(5):608-16. PubMed ID: 22508279
[TBL] [Abstract][Full Text] [Related]
14. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Parkinson's disease: a review of SNCA and LRRK2.
Konno T; Siuda J; Wszolek ZK
Wiad Lek; 2016; 69(3 Pt 1):328-32. PubMed ID: 27486710
[TBL] [Abstract][Full Text] [Related]
16. Japan Parkinson's Progression Markers Initiative (J-PPMI).
Mukai Y; Murata M
Nihon Rinsho; 2017 Jan; 75(1):151-155. PubMed ID: 30566310
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
18. The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.
Polissidis A; Petropoulou-Vathi L; Nakos-Bimpos M; Rideout HJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560161
[TBL] [Abstract][Full Text] [Related]
19. When does Parkinson's disease begin?
Gaig C; Tolosa E
Mov Disord; 2009; 24 Suppl 2():S656-64. PubMed ID: 19877243
[TBL] [Abstract][Full Text] [Related]
20. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
